Press Room


Upcoming Events

  • The 14th International Conference on Alzheimer's and Parkinson's Diseases (ADPD)
  • DateMarch 26-31, 2019
  • LocationLisbon, Portugal

Past Events

  • 21st International Symposium on Signal Transduction at the Blood-Brain Barriers
  • DateSeptember 19-21, 2018
  • LocationArad, Romania
  • XXII International Mass Spectrometry Conference
  • DateAugust 26-31, 2018
  • LocationFlorence, Italy
  • Alzheimer's Association International Conference
  • DateJuly 22-26, 2018
  • LocationChicago, USA
  • XV Discussions in Structural Molecular Biology
  • DateMarch 22-24, 2018
  • LocationNove Hrady, Czech Republic
  • Alzheimer´s Association International Conference
  • DateJuly 16-20, 2017
  • LocationLondon, England
  • The 13th International Conference on Alzheimer´s and Parkinson´s Diseases (ADPD)
  • DateMarch 29-April 2, 2017
  • LocationVienna, Austria
  • 10th International Conference on Frontotemporal Dementias
  • DateAugust 31-September 2, 2016
  • LocationMunich, Germany
  • Alzheimer´s Association International Conference
  • DateJuly 24-28, 2016
  • LocationToronto, Canada
  • 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy
  • DateMarch 9-12, 2016
  • LocationAthens, Greece

The seventh conference on Clinical Trials on Alzheimer's Disease in Philadelphia last month covered everything from a sprinkling of new trial results to a new focus on tau PET imaging to a plea from former FDA honcho Rusty Katz that trialists stop obsessing over disease modification and aggressively pursue big therapeutic effects instead. Madolyn Rogers and Gabrielle Strobel close out their report on the meeting with a look at the role brain amyloid plays in AD, and a review of what new treatments may be in store for 2015.

  • Alzheimer´s Association International Conference
  • DateJuly 18-23, 2015
  • LocationWashington D.C., USA

Join international investigators, clinicians and care providers as they gather to share the latest study results, theories and discoveries that will help bring the world closer to breakthroughs in dementia science.

  • The 12th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders
  • DateMarch 18-22, 2015
  • LocationNice, France

The 12th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PDTM 2015) will build on the well-earned reputation of previous AD/PDTM meetings for unraveling the mechanisms and improving the treatment of Alzheimer's, Parkinson's and other related neurodegenerative diseases. Conference attendees will gain unique and powerful insights into the latest research, developments, and treatments.

  • 7th Clinical Conference on Alzheimer‘s Disease
  • DateNovember 20-22, 2014
  • LocationPhiladelphia, USA

Alzheimer’s disease is one of the most important health challenges facing aging populations worldwide. The development of the next generation of Alzheimer’s disease drugs is becoming essential to face up to this challenge. We learned in San Diego of new pathways identified with biomarkers, facilitating novel trial designs for studies of tau-based therapies and other disease-modifying drugs including immunotherapy.

  • Alzheimer's Association International Conference® 2014
  • DateJuly 12-17, 2014
  • LocationCopenhagen, Denmark

Join us from July 12-17 in Copenhagen for AAIC 2014®, where thousands of researchers from more than 60 countries will gather to reveal the latest study results, theories and discoveries bringing the world closer to breakthroughs in dementia science.

  • 13th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy 2014
  • DateMarch 26-29, 2014
  • LocationGeneva, Switzerland

Leading scientists will discuss new targets and drugs for the treatment of Alzheimer’s disease and novel approaches to current therapy. An oral communication session will be open to young scientists.We expect approximately 1500 participants, mostly neurologists, psychiatrists, geriatricians and pharmacologists.

The Alzheimer's Association International Conference (AAIC) is the world's premier forum for the reporting and discussion of groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer's disease and related disorders. As a part of the Association's research program, AAIC serves as a catalyst for generating new knowledge about Alzheimer's and fostering a vital, collegial research community.

The 6th annual CtaD conference will relate experiences from international teams covering every stage of clinical trials in Alzheimer’s Disease. From animal models to human trials, CtaD 2013 provides an opportunity to learn about the latest results in drug trials as well as important topics such as internet screening of cognition to recruit for clinical trials, designing drug trials taking into account neuropsychiatric symptoms of AD, down syndrome as well as ethical issues and methodological considerations.

AD/PD™ 2013, the 11th International Conference on Alzheimer’s and Parkinson’s Disease, co-organized by Abraham Fisher, Israel Hanin, Roger Nitsch and Manfred Windisch, is a landmark event bringing together over 3,000, neuroscientists, pharmacologists and clinicians to study the hot topics, similarities and differences and scientific breakthroughs associated with Alzheimer’s Disease, Parkinson’s Disease and related neurological disorders, and to evaluate advances that might ameliorate many of these diseases.

  • 8th International Winter Conference on Alzheimer's Disease 2012
  • DateDecember 7-10, 2012
  • LocationZuers, Austria

In a snowy mountain town in Austria, 75 scientists met from 7-10 December 2012 for the 8th International Winter Conference on Alzheimer’s Disease. They traded data and discussion of treatment approaches in the kind of cooped-up, homey atmosphere that brings down barriers when a diverse group of scientists stay together from breakfast until dinner to present, question, and debate science.

Press Releases